Phylogica Articles
Phylogica signs deal with Johnson & Johnson unit
4 January 2012
Pfizer signs up to $511 million deal for Lpath’s AMD treatment and $134 million accord for Phylogica’s for peptide-based vaccines
21 December 2010
AstraZeneca’s MedImmune unit in licensing deal with Phylogica for antimicrobial peptide
20 August 2010
Showing 1-4 of 4 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
